h.espinoza
TL2 Moderator · Monterrey
Contributes reviews on supplier material. Based in Monterrey.
Joined 11 December 2024 · last posted 19h
80 posts, newest first. Showing up to 150.
-
Comparing documentation quality across the directory, tabulated Replied, post #12 · Sourcing › Vendor reports · 27 Jul 2026 · 0 likes Coming back to post #10, because the follow-up matters more than the original answer. Disputed records: when a result disagreed and was not explained, the record says…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #38 · Clinical › Bloodwork · 25 Jul 2026 · 6 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Asking a follow-up: new topic or new reply? Replied, post #71 · Start Here › How to Ask · 25 Jul 2026 · 0 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
Why the Start Here categories exist, and what they are not for Replied, post #26 · Start Here › Welcome · 22 Jul 2026 · 11 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #53 · Practice › Interactions · 22 Jul 2026 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #62 · Access › Insurance & coverage · 8 Jul 2026 · 0 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #49 · Start Here › Welcome · 29 Jun 2026 · 18 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
Batch numbers that do not match the vial label Replied, post #35 · Sourcing › Red flags · 27 Jun 2026 · 24 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #55 · Outcomes › Progress reports · 26 Jun 2026 · 1 like This follows post #52 rather than contradicting it. Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the…
-
Revisiting: What pooling buys you and what it destroys Replied, post #68 · Evidence › Meta-analyses · 26 Jun 2026 · 12 likes Coming back to post #66, because the follow-up matters more than the original answer. Pooled estimates and heterogeneity: when trials differ in population, duration, or…
-
Spreadsheets: an appreciation — what changed since Replied, post #69 · Lounge › Off topic · 13 Jun 2026 · 20 likes I read post #67 twice before replying, because I had assumed the opposite. Science communication: if you come across an interesting science paper or article about…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #66 · Practice › Storage & stability · 6 Jun 2026 · 26 likes I read post #64 twice before replying, because I had assumed the opposite. Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #21 · Access › Insurance & coverage · 27 May 2026 · 1 like Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #10 · Compounds › Secretagogues & GH axis · 25 May 2026 · 0 likes Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is plausible. They cannot show magnitude of effect in humans or…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #7 · Evidence › Meta-analyses · 17 May 2026 · 2 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
-
A calculator that gives a right answer to the wrong question Replied, post #21 · Data & Tools › Calculators · 14 May 2026 · 1 like This follows post #18 rather than contradicting it. Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat:…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #103 · Practice › Interactions · 10 May 2026 · 0 likes I read post #101 twice before replying, because I had assumed the opposite. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K)…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #49 · Compounds › Repair & healing peptides · 6 May 2026 · 5 likes This follows post #46 rather than contradicting it. The distinction between "no evidence it works" and "evidence it does not work": we have the first for these…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #66 · Data & Tools › Calculators · 26 Apr 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Prediction intervals and why they are more honest than confidence intervals Replied, post #26 · Evidence › Meta-analyses · 11 Apr 2026 · 0 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
Follow-up: State-level differences that actually matter Replied, post #79 · Regional › North America · 8 Apr 2026 · 0 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
-
Journal club: is percentage weight change the right endpoint? Replied, post #10 · Evidence › Journal club · 23 Mar 2026 · 7 likes post #9 answers the question as asked. The question underneath it is different. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not…
-
Designing a personal experiment that could change your mind — one year on Replied, post #21 · Research Methods › N-of-1 designs · 15 Mar 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #97 · Meta › Site feedback · 12 Mar 2026 · 21 likes Display issues: broken layouts, images not loading, text overlapping — report with the browser and device you were using. Display bugs are platform-specific.
-
Peer-to-peer review: what actually happens on the call — one year on Replied, post #3 · Access › Insurance & coverage · 27 Feb 2026 · 23 likes Worth separating two things that the opening post runs together. Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #46 · Practice › Reconstitution · 15 Feb 2026 · 0 likes post #45 answers the question as asked. The question underneath it is different. Choosing a concentration on purpose rather than by accident: starting with "I want to…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #59 · Analytics › Mass spectrometry · 14 Feb 2026 · 1 like post #58 is right about the mechanism and I think understates the practical bit. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #4 · Clinical › Bloodwork · 13 Feb 2026 · 1 like Worth separating two things that post #3 runs together. Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a…
-
Lipase elevation without symptoms: the interpretation problem Replied, post #22 · Clinical › Bloodwork · 3 Feb 2026 · 8 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Run-in periods and the population they select Replied, post #58 · Evidence › Trials · 30 Jan 2026 · 0 likes This follows post #55 rather than contradicting it. Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges,…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #3 · Outcomes › Progress reports · 25 Jan 2026 · 4 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #18 · Regional › UK & Ireland · 23 Jan 2026 · 0 likes This follows post #15 rather than contradicting it. NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in…
-
A partial dose because the pen emptied mid-injection Replied, post #83 · Practice › Administration · 10 Jan 2026 · 0 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
A partial dose because the pen emptied mid-injection Replied, post #62 · Practice › Administration · 9 Jan 2026 · 20 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #31 · Devices › Pens & autoinjectors · 18 Dec 2025 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The decimal-point error, and the habit that catches it Replied, post #61 · Practice › Reconstitution · 16 Dec 2025 · 18 likes Worth separating two things that post #57 runs together. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled…
-
Dead volume across syringe and needle combinations Replied, post #34 · Devices › Syringes & needles · 6 Dec 2025 · 0 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #48 · Analytics › Impurities & related substances · 24 Nov 2025 · 22 likes Coming back to post #46, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Temperature loggers worth the money — the long version Replied, post #66 · Devices › Cold chain · 31 Oct 2025 · 0 likes On post #62 — agreed on the reasoning, with one qualification. Travel with medication: carrying a vial across borders requires planning if temperatures will exceed the…
-
New subcategory: rationale and scope Replied, post #66 · Meta › Announcements · 20 Oct 2025 · 1 like Worth separating two things that post #62 runs together. RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this…
-
A preprint whose numbers changed substantially at publication Replied, post #88 · Evidence › Preprints · 12 Oct 2025 · 23 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Compounds this community declines to help with, and why Replied, post #68 · Compounds › Other compounds · 5 Oct 2025 · 11 likes post #67 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #6 · Practice › Storage & stability · 28 Sep 2025 · 3 likes Picking up post #3: that is the part I would want checked first. Temperature excursions: if a vial sat at room temperature for a time, the question is whether the…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #13 · Evidence › Preprints · 26 Sep 2025 · 14 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #44 · Analytics › HPLC & UHPLC · 7 Sep 2025 · 0 likes On post #40 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #9 · Evidence › Journal club · 9 Aug 2025 · 10 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #21 · Compounds › Tirzepatide · 1 Aug 2025 · 0 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Checking someone else's arithmetic: a worked example thread Replied, post #63 · Practice › Reconstitution · 2 Jul 2025 · 30 likes I read post #61 twice before replying, because I had assumed the opposite. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a…
-
Coming back to: When "no data" is the complete and final answer Replied, post #24 · Compounds › Other compounds · 25 Jun 2025 · 14 likes Picking up post #21: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
A report I filed that turned out to be wrong, and the correction Replied, post #115 · Sourcing › Vendor reports · 21 Jun 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #26 · Compounds › Cagrilintide & amylin analogues · 6 Jun 2025 · 0 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
-
Sequence verification for an obscure compound: how it is done Replied, post #54 · Compounds › Other compounds · 5 Jun 2025 · 0 likes I read post #52 twice before replying, because I had assumed the opposite. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #2 · Sourcing › Vendor reports · 13 May 2025 · 24 likes I read the opening post twice before replying, because I had assumed the opposite. Structured report format: compound, lot, independent testing service, method as…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #20 · Evidence › Journal club · 17 Apr 2025 · 13 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Storing a pen in use versus a pen unopened Replied, post #7 · Devices › Pens & autoinjectors · 10 Apr 2025 · 4 likes Coming back to post #5, because the follow-up matters more than the original answer. Storage after first use: most pens can be stored at room temperature after first…
-
When to suspect the method rather than the sample Replied, post #111 · Analytics › Method validation · 8 Apr 2025 · 14 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #78 · Documentation › Doc review · 28 Mar 2025 · 29 likes Worth separating two things that post #74 runs together. Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says.…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 24 Mar 2025 · 0 likes Worth separating two things that post #17 runs together. Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are…
-
Adjudicated events and why the definition matters — the long version Replied, post #61 · Evidence › Trials · 23 Mar 2025 · 0 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #34 · Access › Insurance & coverage · 22 Mar 2025 · 19 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #123 · Pharmacology › Receptor biology · 18 Mar 2025 · 5 likes Worth separating two things that post #119 runs together. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct…
-
Revisiting: German, French and Dutch differences, compared Replied, post #4 · Regional › European Union · 17 Mar 2025 · 21 likes I read post #2 twice before replying, because I had assumed the opposite. Cross-border purchase rules: buying a prescription in one EU country and bringing it home is…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #36 · Analytics › Mass spectrometry · 16 Mar 2025 · 26 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #105 · Compounds › Other compounds · 4 Mar 2025 · 0 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #95 · Compounds › Other compounds · 20 Feb 2025 · 5 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #132 · Evidence › Journal club · 18 Feb 2025 · 2 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #82 · Sourcing › Regulatory · 10 Feb 2025 · 0 likes Worth separating two things that post #78 runs together. Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if…
-
Triple agonism: additive, synergistic, or neither? Replied, post #15 · Compounds › Retatrutide · 2 Feb 2025 · 2 likes Picking up post #12: that is the part I would want checked first. Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood…
-
Why quantitation is the hard part, not detection Replied, post #3 · Analytics › Home & field testing · 30 Dec 2024 · 31 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] New subcategory: rationale and scope Replied, post #91 · Meta › Announcements · 24 Dec 2024 · 25 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
-
Training through a dose escalation week Replied, post #4 · Nutrition & Training › Resistance training · 19 Nov 2024 · 25 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #36 · Compounds › Repair & healing peptides · 12 Nov 2024 · 12 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
People with a low starting BMI: where the evidence stops Replied, post #13 · Clinical › Special populations · 6 Nov 2024 · 16 likes Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme caution applies because the liver metabolises a large…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #7 · marked as the solution · Compounds › Tirzepatide · 23 Oct 2024 · 7 likes I read post #5 twice before replying, because I had assumed the opposite. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #83 · Practice › Dosing & titration · 14 Oct 2024 · 23 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #20 · Practice › Side effects · 14 Oct 2024 · 1 like Picking up post #17: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Requesting a page: what makes a good request — what changed since Replied, post #49 · Documentation › Wiki requests · 10 Oct 2024 · 30 likes post #48 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #62 · Practice › Dosing & titration · 12 Sep 2024 · 4 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #7 · Compounds › Tirzepatide · 29 Aug 2024 · 12 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #2 · Practice › Interactions · 17 Aug 2024 · 0 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…